{"url":"https://lda.senate.gov/api/v1/filings/9e02afdb-e350-4ce7-82c4-4ab531bbddb6/","filing_uuid":"9e02afdb-e350-4ce7-82c4-4ab531bbddb6","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2008,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/9e02afdb-e350-4ce7-82c4-4ab531bbddb6/print/","filing_document_content_type":"text/html","income":null,"expenses":"441145.79","expenses_method":"c","expenses_method_display":"Method C - Reporting amounts under section 162(e) of the Internal Revenue Code","posted_by_name":"Valli Baldassano, Executive Vice President & Chief Compliance Officer","dt_posted":"2009-01-21T13:26:59-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"41 Moores Rd","registrant_address_2":"PO Box 4011","registrant_different_address":false,"registrant_city":"Frazer","registrant_state":"PA","registrant_zip":"19355","registrant":{"id":8761,"url":"https://lda.senate.gov/api/v1/registrants/8761/","house_registrant_id":33486,"name":"CEPHALON, INC.","description":null,"address_1":"41 Moores Rd","address_2":"PO Box 4011","address_3":null,"address_4":null,"city":"Frazer","state":"PA","state_display":"Pennsylvania","zip":"19355","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GERALD J. PAPPERT","contact_telephone":"+1 610-738-6337","dt_updated":"2022-04-06T16:07:55.984950-04:00"},"client":{"id":112891,"url":"https://lda.senate.gov/api/v1/clients/112891/","client_id":12,"name":"CEPHALON INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"PA","state_display":"Pennsylvania","country":"US","country_display":"United States of America","ppb_state":"PA","ppb_state_display":"Pennsylvania","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-07-31"},"lobbying_activities":[{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Brazillian intellectual property issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":43720,"prefix":"mr","prefix_display":"MR.","first_name":"JEFF","nickname":null,"middle_name":"M","last_name":"MYERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":64,"name":"Federal Trade Commission (FTC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":193,"name":"Natl Institute on Alcohol Abuse & Alcoholism (NIAA)"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"H.R. 1908-Patent Reform Act, provisions related to pharmaceutical patents\nH.R. 1432-Preserve Access to Affordable Generics Act, to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":43720,"prefix":"mr","prefix_display":"MR.","first_name":"JEFF","nickname":null,"middle_name":"M","last_name":"MYERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":64,"name":"Federal Trade Commission (FTC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":193,"name":"Natl Institute on Alcohol Abuse & Alcoholism (NIAA)"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Support for additional FDA resources. Support for SAMHSA funding. HHS Education Appropriations.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":43720,"prefix":"mr","prefix_display":"MR.","first_name":"JEFF","nickname":null,"middle_name":"M","last_name":"MYERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":64,"name":"Federal Trade Commission (FTC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":193,"name":"Natl Institute on Alcohol Abuse & Alcoholism (NIAA)"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"ALC","general_issue_code_display":"Alcohol and Drug Abuse","description":"Access and reimbursement issues regarding Alcohol pharmacotherapies. \nH.R. 1424/S. 558 - Paul Wellstone Mental Health and Addiction Equity Act of 2007, parity related issues. Departments of Labor, Health & Human Services, and Education, and Related Agencies Appropriations Act, FY 2009, addiction treatment issues. \nMilitary Construction and Veterans Affairs Appropriations Act, FY 2009, veterans access to addiction treatment issues.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":43720,"prefix":"mr","prefix_display":"MR.","first_name":"JEFF","nickname":null,"middle_name":"M","last_name":"MYERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":64,"name":"Federal Trade Commission (FTC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":193,"name":"Natl Institute on Alcohol Abuse & Alcoholism (NIAA)"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S.2029-Physician Payments Sunshine Act of 2007\nH.R.5613-Protecting the Medicaid Safety Net Act\nH.R.3610-Food & Drug Import Safety Act\nH.R.4-Medicare Prescription Drug Price Negotiation Act of 2007              Comparative Effectiveness in H.R.3162","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":43720,"prefix":"mr","prefix_display":"MR.","first_name":"JEFF","nickname":null,"middle_name":"M","last_name":"MYERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":64,"name":"Federal Trade Commission (FTC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":193,"name":"Natl Institute on Alcohol Abuse & Alcoholism (NIAA)"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}